🇺🇸 FDA

Company profile · Sponsor

Sun

Sun Yat-sen University

C419F26 · NMPA pharma CN
Pipeline
19
Drugs
0
Patents
0

Quick answer

Sun (C419F26) is a pharma company. headquartered in CN. listed on NMPA. NovaPharmaNews links 19 pipeline programs, 0 drugs, and 0 patents to this profile..

Company facts

Ticker C419F26
Exchange NMPA
Company type pharma
Headquarters CN

Pipeline (19)

Search pipeline →

  1. Chemotherapy

    Sun

    Nasopharyngeal Carcinoma

    phase 3 small molecule active

    1 trial

  2. Cytokine-Induced Killer Cells

    Sun

    Carcinoma, Hepatocellular

    phase 3 mab completed

    1 trial

  3. Palliative Chemotherapy

    Sun

    Colorectal Neoplasms Malignant

    phase 3 small molecule active

    1 trial

  4. gemcitabine and cisplatin (Induction chemotherapy)

    Sun

    Nasopharyngeal Carcinoma

    phase 3 small molecule active

    1 trial

  5. postoperative antimicrobial prophylaxis

    Sun

    Hepatocellular Carcinoma

    phase 3 small molecule on hold

    1 trial

  6. Almonertinib

    Sun

    Safety of Almonertinib

    phase 2 small molecule active

    1 trial

  7. Bone marrow mesenchymal stem cells (low dose)

    Sun

    Acute-On-Chronic Liver Failure

    phase 2 small molecule active

    1 trial

  8. Chidamide

    Sun

    Peripheral T-cell Lymphoma

    phase 2 small molecule active

    1 trial

  9. Online adaptive SBRT

    Sun

    Adaptive Radiotherapy

    phase 2 other active

    1 trial

  10. Probiotics Compound (Biolosion)

    Sun

    Advanced Urothelial Carcinoma

    phase 2 small molecule active

    1 trial

  11. Pucotenlimab

    Sun

    Colorectal Cancer (CRC)

    phase 2 small molecule active

    1 trial

  12. Surufatinib + Serplulimab+Albumin-paclitaxel + Gemcitabine

    Sun

    Locally Advanced Pancreatic Cancer

    phase 2 small molecule active

    1 trial

  13. TPC induction chemotherapy

    Sun

    Nasopharyngeal Carcinoma

    phase 2 small molecule active

    1 trial

  14. furmonertinib

    Sun

    Non-small Cell Lung Cancer Metastatic

    phase 2 small molecule completed

    1 trial

  15. Concurrent chemotherapy

    Sun

    Locally Advanced Lung Carcinoma

    phase 1 small molecule completed

    1 trial

  16. Benazepril

    Sun

    Renal Function Disorder

    small molecule completed

    1 trial

  17. Probiotics

    Sun

    Cardiometabolic Risk Factors

    other completed

    1 trial

  18. Terlipressin

    Sun

    Septic Shock

    small molecule active

    1 trial

  19. araboxylan

    Sun

    Subjects With Hyperuricemia

    other active

    1 trial

Frequently asked questions

What is Sun?

Sun (C419F26) is a pharma company. headquartered in CN. listed on NMPA. NovaPharmaNews links 19 pipeline programs, 0 drugs, and 0 patents to this profile..

What pipeline programs does Sun sponsor?

We track 19 ClinicalTrials.gov-linked programs for Sun, including Chemotherapy and 18 more. Open each program for phase, modality, NCT IDs, and indication details.

Where does Sun company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.